Natixis grew its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 6.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 326,032 shares of the real estate investment trust's stock after buying an additional 18,533 shares during the period. Natixis' holdings in Healthpeak Properties were worth $6,609,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Principal Financial Group Inc. raised its holdings in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the last quarter. Norges Bank bought a new stake in shares of Healthpeak Properties in the 4th quarter worth $166,804,000. Long Pond Capital LP purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $86,885,000. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. Finally, National Bank of Canada FI boosted its position in shares of Healthpeak Properties by 56,120.9% during the fourth quarter. National Bank of Canada FI now owns 1,686,065 shares of the real estate investment trust's stock valued at $34,181,000 after buying an additional 1,683,066 shares during the last quarter. Institutional investors own 93.57% of the company's stock.
Analyst Ratings Changes
Several equities analysts have issued reports on DOC shares. Wedbush restated an "outperform" rating and set a $24.00 target price on shares of Healthpeak Properties in a research note on Friday, April 11th. StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Wednesday. Robert W. Baird cut their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. Scotiabank lowered their price target on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a report on Friday, February 28th. Finally, Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price objective for the company in a report on Wednesday, January 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $23.83.
Check Out Our Latest Stock Analysis on DOC
Healthpeak Properties Price Performance
Shares of NYSE DOC traded up $0.02 during mid-day trading on Wednesday, reaching $18.83. The company's stock had a trading volume of 4,721,747 shares, compared to its average volume of 4,899,434. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a 52 week low of $17.33 and a 52 week high of $23.26. The stock has a fifty day moving average of $19.62 and a two-hundred day moving average of $20.62. The firm has a market capitalization of $13.17 billion, a PE ratio of 53.80, a P/E/G ratio of 2.17 and a beta of 1.02.
Healthpeak Properties Dividend Announcement
The business also recently disclosed a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.1017 per share. This represents a yield of 6.5%. The ex-dividend date is Thursday, April 17th. Healthpeak Properties's dividend payout ratio (DPR) is currently 348.57%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.